Holen Sie sich die Stockscreener-App
46.68
0.41%
-0.19
Handel nachbörslich:
46.68
Schlusskurs vom Vortag:
$46.87
Offen:
$46.64
24-Stunden-Volumen:
437.31K
Relative Volume:
1.06
Marktkapitalisierung:
$1.62B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-91.00M
KGV:
-12.72
EPS:
-3.67
Netto-Cashflow:
$-74.38M
1W Leistung:
-1.46%
1M Leistung:
-1.00%
6M Leistung:
-26.43%
1J Leistung:
+34.80%
1-Tages-Spanne:
$44.47
$47.22
1-Wochen-Bereich:
$44.47
$48.83
52-Wochen-Spanne:
$30.82
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
Firmenname
Disc Medicine Inc
Sektor
Branche
Telefon
(617) 674-9274
Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN
Vergleichen Sie IRON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
46.68 | 1.64B | 0 | -91.00M | -74.38M | -3.67 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-27 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-05-17 | Eingeleitet | Raymond James | Outperform |
| 2023-04-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Eingeleitet | Stifel | Buy |
| 2023-04-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-03-23 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-02-28 | Eingeleitet | SVB Securities | Outperform |
Alle ansehen
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Disc Medicine to Participate in Upcoming Investor Conferences - GlobeNewswire
Disc Medicine Sets Double Conference Appearance: Jefferies and Goldman Sachs Healthcare Events - Stock Titan
BNP Paribas Financial Markets Invests $324,000 in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Stock Position Raised by Deutsche Bank AG - Defense World
Disc Medicine Shows Improved Relative Price Performance; Still Shy Of Benchmark - MSN
Insider Sell: William Savage Sells Shares of Disc Medicine Inc (IRON) - GuruFocus
Disc Medicine’s chief medical officer sells $334,128 in stock By Investing.com - Investing.com Canada
Disc Medicine’s chief medical officer sells $334,128 in stock - Investing.com
Porphyria Pipeline 2025: Groundbreaking Clinical - openPR.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Northern Trust Corp - Defense World
Commit To Buy Disc Medicine At $35, Earn 14.1% Annualized Using Options - Nasdaq
Disc Medicine Announces Multiple Presentations Across Portfolio - GuruFocus
Disc Medicine, Inc. to Present Key Data from Hematology Portfolio at EHA 2025 Congress - Nasdaq
Disc Medicine Announces Multiple Presentations Across - GlobeNewswire
Disc Medicine Reveals First Disease-Modifying EPP Treatment Data Among 6 Clinical Updates at EHA 2025 - Stock Titan
BMO Capital Markets Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - Defense World
Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference - The Manila Times
Tower Research Capital LLC TRC Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
How To Trade (IRON) - news.stocktradersdaily.com
Disc Medicine (IRON) Price Target Raised by BMO Capital | IRON S - GuruFocus
Promising Outlook for Disc Medicine’s DISC-0974 in Anemia Treatment Justifies Buy Rating - TipRanks
BMO Capital Boosts Price Target for Disc Medicine (IRON) to $120 - GuruFocus
Cantor Fitzgerald Comments on Disc Medicine FY2025 Earnings - Defense World
Q2 EPS Estimates for Disc Medicine Cut by Leerink Partnrs - Defense World
Insider Sellers Might Regret Selling Disc Medicine Shares at a Lower Price Than Current Market Value - simplywall.st
Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by Dimensional Fund Advisors LP - Defense World
Wedbush Issues Negative Forecast for Disc Medicine Earnings - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Disc Medicine Reports Strong Q1 2025 Progress - TipRanks
Here's Why We're Not Too Worried About Disc Medicine's (NASDAQ:IRON) Cash Burn Situation - Yahoo Finance
Decoding Disc Medicine Inc (IRON): A Strategic SWOT Insight - GuruFocus
Market Resilience: Disc Medicine Inc (IRON) Finishes Weak at 42.58, Down -12.40 - DWinneX
Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Disc Medicine reports Q1 EPS ($1.02), consensus ($1.07) - TipRanks
Disc Medicine, Inc. SEC 10-Q Report - TradingView
Disc Medicine Inc (IRON) Reports Q1 2025 EPS of -$1.02, Aligns with Estimates; Strong Cash Position of $694.7 Million - GuruFocus
Disc's Bitopertin Program Advances with APOLLO Trial Launch | IRON Stock News - GuruFocus
Disc Medicine, Inc. Reports Q1 2025 Financial Results and Updates on Bitopertin and Pipeline Programs - Nasdaq
Invesco Ltd. Increases Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
(IRON) On The My Stocks Page - news.stocktradersdaily.com
Wells Fargo & Company MN Grows Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF) - The Manila Times
Leading Cancer Centers Join Forces to Review Breakthrough Myelofibrosis Anemia Treatment Data - Stock Titan
JPMorgan Chase & Co. Purchases 44,762 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Renaissance Technologies LLC Makes New $5.48 Million Investment in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
When (IRON) Moves Investors should Listen - news.stocktradersdaily.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Geode Capital Management LLC - Defense World
New GlyT-1 inhibitors disclosed in Disc Medicine patent - BioWorld MedTech
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of “Buy” by Brokerages - Defense World
Disc Medicine price target raised to $132 from $99 at Cantor Fitzgerald - MSN
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.89%
3.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):